MSD
The Development and Commercialization Team (DCT) Leader is accountable for defining and delivering an integrated CMC development and commercialization strategy for the company’s biologics portfolio. The role provides senior technical leadership across functions and represents CMC in governance to ensure stage-appropriate development and successful product launch.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Senior Director, CMC Development, Biologics
Flagship Pioneering, Inc.
Vice President, Biologics Process Development
Ipsen
ED/VP Commercial CMC North America
WuXi Biologics
Senior Director, CMC Technical Operations, siRNA Therapeutics
Alector
CMC Lead – Neurotoxins & Biologics
Ipsen
Development and Commercialization Team (DCT) Leader
Merck & Co., Inc.